To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Phone: 248-922-6600
Karmanos Cancer Institute at McLaren Clarkston brings world-class cancer care and clinical research close to home. We know that navigating a cancer diagnosis can be an overwhelming process. By providing access to leading oncology treatment, imaging, counseling, and other related services to patients and their families living in and around Clarkston, Michigan, our goal is help minimize some of the stress. Please don't hesitate to contact us to learn more about how we can help you battle cancer.
Oncology - Radiation
Genetics
Oncology - Hematology
Oncology - Hematology, Oncology - Medical
Oncology - Surgical, Surgery - Breast
Cardiothoracic Surgery, Surgery - Cardiothoracic, Surgery - Thoracic
The Barbara Ann Karmanos Cancer Institute , the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center, is...
Lauren Lawrence, vice president of the Karmanos Cancer Network, joins CANdid Connection to talk about celebrating cancer survivors and how Karmano...
Congratulations are again in order for McLaren Health Care president and CEO Philip A. Incarnati and Dr. Gerold Bepler, president and CEO of Barba...